Molecular testing to deliver personalized chemotherapy recommendations: risking over and undertreatment

BACKGROUND: In the adjuvant setting of cancer treatment, de-escalation strategies have the goal of omitting or minimizing treatment in patients, without compromising outcomes. Historically, eligibility for adjuvant treatment solely relied on the patient’s clinical and tumor’s pathological characteri...

Descripción completa

Detalles Bibliográficos
Autores principales: Olivier, Timothée, Prasad, Vinay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Debate
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644653/
https://www.ncbi.nlm.nih.gov/pubmed/36348413
http://dx.doi.org/10.1186/s12916-022-02589-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644653/
https://www.ncbi.nlm.nih.gov/pubmed/36348413
http://dx.doi.org/10.1186/s12916-022-02589-6

Ejemplares similares